Advertisement
Research Article| Volume 116, ISSUE 6, P1111-1117, December 1994

Hepatic arterial chemoembolization for metastatic neuroendocrine tumors

  • Laura J. Perry
    Correspondence
    Reprint requests: Laura J. Perry, MD, Department of Radiological Sciences, Section of Angiography and Interventional Radiology, Deaconess Hospital, 185 Pilgrim Rd., Boston, MA 02215.
    Affiliations
    Department of Radiological Sciences, Section of Angiography and Interventional Radiology, and the Department of Medical Oncology, Deaconess Hospital, Boston, Mass., USA
    Search for articles by this author
  • Keith Stuart
    Affiliations
    Department of Radiological Sciences, Section of Angiography and Interventional Radiology, and the Department of Medical Oncology, Deaconess Hospital, Boston, Mass., USA
    Search for articles by this author
  • Kenneth R. Stokes
    Affiliations
    Department of Radiological Sciences, Section of Angiography and Interventional Radiology, and the Department of Medical Oncology, Deaconess Hospital, Boston, Mass., USA
    Search for articles by this author
  • Melvin E. Clouse
    Affiliations
    Department of Radiological Sciences, Section of Angiography and Interventional Radiology, and the Department of Medical Oncology, Deaconess Hospital, Boston, Mass., USA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Background. Patients with neuroendocrine neoplasms, even with metastases to the liver, often have indolent disease and are treated conservatively. However, when debilitating symptoms from hormonal syndromes or mass effect arise, more aggressive treatment may be warranted.
      Methods. Thirty-nine chemoembolization procedures were performed in 30 patients with significant symptoms, with carcinoids and islet cell tumors. An emulsification of introarterial doxorubicin, iodized oil, and water-soluble contrast was followed by embolization with absorbable gelatin powder or pledgets.
      Results. Twenty-seven patients exhibited subjective improvement in clinical symptoms. Hormonal markers and/or tumor size decreased by at least 50% in 79% of patients. Inclusion of minor responses raises this to 92%. Seven complications were noted, and no procedure-related deaths occurred. Median survival was 24 months after chemoembolization or 53 months after diagnosis. Computed tomographic features of tumor vascularity, distribution of metastatic lesions, and distribution of ethiodized oil were not clearly correlated with outcome. Presence of a nonresected primary tumor had a negative effect on survival.
      Conclusions. Compared with previously described treatments for neuroendocrine liver metastases, this technique appears to be more effective and to be associated with less morbidity, and is recommended for patients with significant symptoms who have failed to respond to more conservative therapy and who are not surgical candidates.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Marlink R.G.
        • Lokich J.J.
        • Robins J.R.
        • Clouse M.E.
        Hepatic arterial embolization for metastatic hormone-secreting tumors.
        Cancer. 1990; 65: 2227-2232
        • McEntee G.P.
        • Nagorney D.M.
        • Kvols L.K.
        • Moertel C.G.
        • Grant C.S.
        Cytoreductive hepatic surgery for neuroendocrine tumors.
        Surgery. 1990; 108: 1091-1096
        • Moertel C.G.
        Karnofsky Memorial Lecture: an odyssey in the land of small tumors.
        J Clin Oncol. 1987; 5: 1503-1522
        • Hajarizadeh H.
        • Ivancer K.
        • Mueller C.R.
        • Fletcher W.S.
        • Woltering E.A.
        Effective palliative treatment of metastatic carcinoid tumors with intra-arterial chemotherapy/chemoembolization combined with octreotide acetate.
        Am J Surg. 1992; 163: 479-482
        • Kvols L.K.
        • Buck M.
        Chemotherapy of metastatic carcinoid and islet cell tumors.
        Am J Med. 1987; 82: 77-83
        • Martin Jr, K.
        • Moertel C.G.
        • Adson M.A.
        • Schutt A.J.
        Surgical treatment of functioning metastatic carcinoid tumors.
        Arch Surg. 1993; 118: 537-542
        • Galland R.B.
        • Blumgart L.H.
        Carcinoid syndrome: surgical management.
        Br J Hosp Med. 1986; 35: 166-170
        • Moertel C.G.
        • Lefkopoulo M.
        • Lipsitz S.
        • Hahn R.G.
        • Klaassen D.
        Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet cell carcinoma.
        N Engl J Med. 1992; 326: 519-523
        • Creutzfeldt W.
        • Stöckmann F.
        Carcinoids and carcinoid syndrome.
        Am J Med. 1987; 82: 4-16
        • Moertel C.G.
        • Johnson C.M.
        • McKusick M.A.
        • et al.
        The management of patients with advanced carcinoid tumors and islet cell carcinomas.
        Ann Intern Med. 1994; 120: 302-309
        • Ajani J.A.
        • Carrasco C.H.
        • Charnsangavej C.
        • Samaan N.A.
        • Levin B.
        • Wallace S.
        Islet cell tumors metastatic to the liver: effective palliation by sequential hepatic artery embolization.
        Ann Intern Med. 1988; 108: 340-344
        • Allison D.J.
        • Jordan H.
        • Hennessy O.
        Therapeutic embolization of the hepatic artery: a review of 75 procedures.
        Lancet. 1985; 1: 595-599
        • Carrasco C.H.
        • Chamsagavej C.
        • Ajani J.
        • Samaan N.A.
        • Richli W.
        • Wallace S.
        The carcinoid syndrome: palliation by hepatic artery embolization.
        AJR. 1986; 147: 149-154
        • Nakao N.
        • Minra K.
        • Tadahashi H.
        • et al.
        Hepatocellular carcinoma: combined hepatic arterial and portal venous embolization.
        Radiology. 1986; 161: 303-307
        • Matsuo N.
        • Uchida H.
        • Nishimine K.
        • et al.
        Segmental transcatheter hepatic artery chemoembolization with iodized oil for hepatocellular carcinoma: antitumor effect and influence on normal tissue.
        J Vase Interv Radiol. 1993; 4: 543-549
        • Stuart K.
        • Stokes K.
        • Jenkins R.
        • Trey C.
        • Clouse M.
        Treatment of hepatocellular carcinoma using doxorubicin,/ethiodized oil/ gelatin powder chemoembolization.
        Cancer. 1993; 72: 3202-3209
        • Kan Z.
        • Ivancev K.
        • Hägerstrand I.
        • Chuang V.P.
        • Lunderquist A.
        In vivo microscopy of the liver after injection of lipiodol in the hepatic artery and portal vein of the rat.
        Actor Radiol. 1989; 30: 419-425
        • Kruskal J.B.
        • Hlatky L.
        • Hahnfeldt P.
        • Teramoto K.
        • Stokes K.R.
        • Clouse M.E.
        In vivo and in vitro analysis of the effectiveness of doxorubicin combined with temporary arterial occlusion.
        J Vasc Interv Radiol. 1993; 4: 741-747
        • Therasse E.
        • Breittmayer F.
        • Roche A.
        • et al.
        Transcatheter chemoembolization of progressive carcinoid liver metastasis.
        Radiology. 1993; 189: 541-547
        • Ruszniewski P.
        • Rougher P.
        • Roche A.
        • et al.
        Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors: a prospective phase II study in 24 patients.
        Cancer. 1993; 71: 2624-2630
        • Godwin II, J.D.
        Carcinoid tumors: an analysis of 2837 cases.
        Cancer. 1980; 45: 104-110
        • Öberg K.
        • Norheim I.
        • Lind E.
        • et al.
        Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results.
        Cancer Treat Rep. 1986; 70: 1299-1304
        • Hanssen L.E.
        • Schumpf E.
        • Kolbenstredt A.N.
        • Tausj J.
        • Dolva L.
        Recombinant a2 interferon with or without hepatic artery emholization in the treatment of midgut carcinoid tumors.
        Actor Oncol. 1989; 28: 439-443